BNP Paribas Asset Management
ZYME icon

BNP Paribas Asset Management’s Zymeworks ZYME Stock Holding History

BNP Paribas Asset Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.6M Sell
1,781,116
-126,923
-7% -$3.22M 0.05% 362
2026
Q1 		$47.8M Buy
1,908,039
+85,991
+5% +$2.03M 0.06% 326
2025
Q4 		$48M Buy
+1,822,048
New +$39.7M 0.06% 313
2025
Q3 		– Sell
-2,039,656
Closed -$25.6M – 2103
2025
Q2 		$25.6M Sell
2,039,656
-158,223
-7% -$1.88M 0.06% 294
2025
Q1 		$26.2M Buy
2,197,879
+60,226
+3% +$821K 0.07% 267
2024
Q4 		$31.3M Buy
2,137,653
+192,162
+10% +$2.69M 0.08% 252
2024
Q3 		$24.4M Buy
1,945,491
+14,604
+0.8% +$159K 0.06% 279
2024
Q2 		$16.4M Buy
1,930,887
+23,173
+1% +$206K 0.04% 330
2024
Q1 		$20.1M Buy
1,907,714
+135,938
+8% +$1.51M 0.05% 304
2023
Q4 		$18.4M Buy
1,771,776
+213,525
+14% +$1.7M 0.05% 312
2023
Q3 		$9.88M Sell
1,558,251
-616,349
-28% -$4.55M 0.03% 406
2023
Q2 		$18.8M Sell
2,174,600
-131,872
-6% -$1.18M 0.06% 301
2023
Q1 		$20.9M Buy
2,306,472
+14,665
+0.6% +$128K 0.07% 284
2022
Q4 		$18M Buy
2,291,807
+782,770
+52% +$5.5M 0.06% 320
2022
Q3 		$9.28M Buy
1,509,037
+70,818
+5% +$427K 0.04% 422
2022
Q2 		$7.62M Buy
1,438,219
+146,566
+11% +$886K 0.03% 452
2022
Q1 		$8.46M Buy
1,291,653
+145,935
+13% +$1.3M 0.03% 435
2021
Q4 		$18.8M Buy
1,145,718
+296,993
+35% +$6.19M 0.06% 332
2021
Q3 		$24.6M Buy
848,725
+61,941
+8% +$2.06M 0.09% 253
2021
Q2 		$27.3M Buy
786,784
+53,227
+7% +$1.69M 0.1% 251
2021
Q1 		$23.2M Buy
733,557
+96,236
+15% +$3.91M 0.1% 248
2020
Q4 		$30.1M Sell
637,321
-56,465
-8% -$2.62M 0.14% 189
2020
Q3 		$32.3M Buy
693,786
+259,299
+60% +$8.9M 0.18% 144
2020
Q2 		$15.7M Buy
434,487
+36,321
+9% +$1.34M 0.11% 232
2020
Q1 		$14.1M Buy
398,166
+93,244
+31% +$3.82M 0.12% 213
2019
Q4 		$13.9M Sell
304,922
-131,017
-30% -$4.76M 0.09% 256
2019
Q3 		$10.8M Sell
435,939
-20,145
-4% -$505K 0.08% 289
2019
Q2 		$10M Buy
+456,084
New +$8.37M 0.08% 294

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BNP Paribas Asset Management's ZYME Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its Zymeworks (ZYME) stake by 6.7% in Q2 2026, selling an estimated $3.22M and leaving 1,781,116 shares worth $46.6M. The position accounts for 0.05% of the portfolio, ranked #362.

BNP Paribas Asset Management first reported a position in ZYME in Q2 2019 and has held it in 28 quarters since. The position peaked at $48M in Q4 2025. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • BNP Paribas Asset Management held 1,781,116 shares of Zymeworks worth $46.6M as of Q2 2026.
  • BNP Paribas Asset Management sold 126,923 Zymeworks shares in Q2 2026, an estimated $3.22M.
  • Zymeworks made up 0.05% of BNP Paribas Asset Management's portfolio in Q2 2026, its #362 holding.
  • BNP Paribas Asset Management first reported a position in Zymeworks in Q2 2019 and has held it in 28 quarters since.
  • BNP Paribas Asset Management's Zymeworks position peaked at $48M in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.